Ovid Therapeutics Appoints Petra Kaufmann as Chief Medical Officer

Ovid Therapeutics has appointed Petra Kaufmann as Chief Medical Officer to guide the company's clinical, medical, and regulatory strategy. Kaufmann has extensive experience in developing CNS therapeutics and has held leadership roles in biopharmaceutical companies and at the National Institutes of Health. She will oversee the advancement of Ovid's pipeline of potential therapeutic candidates, including OV329 and its broad portfolio of KCC2 direct activators.